Drug profile · INN
sulfur hexafluoride lipid-type a microspheres
LUMASON
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sulfur hexafluoride lipid-type a microspheres (LUMASON) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is sulfur hexafluoride lipid-type a microspheres?
sulfur hexafluoride lipid-type a microspheres (LUMASON) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for sulfur hexafluoride lipid-type a microspheres?
LUMASON is a marketed brand name for sulfur hexafluoride lipid-type a microspheres. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfur hexafluoride lipid-type a microspheres?
sulfur hexafluoride lipid-type a microspheres has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.